drugset / Trial / NCT03608579

Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA

NCT03608579

Phase 1 Active not recruiting 24 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

Will injection(s) of autologous culture-expanded AMSCs be safe and efficacious for treatment of painful Hip OA, and if so, which dosing regimen is most effective?

Timeline

Start
2018-11-05
Primary completion
2026-10
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Adipose-Derived Mesenchymal Stromal Cells Cell therapy 3e+07 cells Other

Indications